Synlogic, Inc.

SYBX Biotech & pharma

Develops drugs for various diseases.

Jun 2026Revenue $0.00/yrExpenses $4.66M/yr
No trendCash runway ≈ 3.4 years from Jun 2026
Figures by year

When will Synlogic be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $0.00 and expenses $4.66M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$0.00$4.01M−$4.01M
Dec 2024$8.00K$41.0M−$41.0M
Dec 2023$3.37M$58.5M−$55.2M
Dec 2022$1.18M$68.6M−$67.4M
Dec 2021$1.75M$62.5M−$60.8M
Dec 2020$545K$61.0M−$60.5M
Dec 2019$2.22M$56.6M−$54.4M
Dec 2018$2.52M$53.8M−$51.2M
Dec 2017$2.44M$43.3M−$40.8M
Dec 2016$444K$21.4M−$21.0M